Secretion of a Novel, Developmentally Regulated Fatty Acid-binding Protein into the Perivitelline Fluid of the Parasitic Nematode, Ascaris suum*

(Received for publication, November 8, 1996, and in revised form, January 17, 1997)

Baisong Mei Dagger , Malcolm W. Kennedy §, Jeremy Beauchamp , Patricia R. Komuniecki Dagger and Richard Komuniecki Dagger par

From the Dagger  Department of Biology, The University of Toledo, Toledo, Ohio 43606-3390, the § Division of Infection and Immunity, Institute of Biomedical and Life Sciences, and  Protein Crystallography, Department of Chemistry, University of Glasgow, Glasgow G12 8QQ, United Kingdom

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES


ABSTRACT

Early development of the parasitic nematode, Ascaris suum, occurs inside a highly resistant eggshell, and the developing larva is bathed in perivitelline fluid. Two-dimensional gel analysis of perivitelline fluid from infective larvae reveals seven major proteins; a cDNA encoding one of these, As-p18, has been cloned, sequenced, and protein expressed in Escherichia coli. The predicted amino acid sequence of As-p18 exhibits similarities to the intracellular lipid-binding protein (iLBP) family including retinoid- and fatty acid-binding proteins (FABP). As-p18 is unusual in that it possesses a hydrophobic leader that is not present in the mature protein, the developmental regulation of its expression, and in terms of its predicted structure.

Recombinant As-p18 is a functional FABP with a high affinity for both a fluorescent fatty acid analog (11(((5-(dimethylamino)-1-naphthalenyl)sulfonyl)amino) undecanoic acid) and oleic acid, but not retinol. Circular dichroism of rAs-p18 reveals a high beta -sheet content (62%), which is consistent with secondary structure for the protein predicted from sequence algorithms, and the structure of iLBPs. Unusual features are apparent in a structural model of As-p18 generated from existing crystal structures of iLBPs.

As-p18 is not found in unembryonated eggs, begins to be synthesized at about day 3 of development, reaches a maximal concentration with the formation of the first-stage larva and remains abundant in the perivitelline fluid of the second-stage larva. Since As-p18 is not present in the post-infective third-stage larva or adult worm tissues, it appears to be exclusive to the egg. Surprisingly, however, Northern blot analysis yields mRNA for As-p18 not only in the early larval stages, but also the unembryonated egg, third-stage larvae, and ovaries of adult worms, even though the protein is not detectable from any of those sources. As-p18 may play a role in sequestering potentially toxic fatty acids and their peroxidation products, or it may be involved in the maintenance of the impermeable lipid layer of the eggshell.


INTRODUCTION

Parasitic nematodes cause medical and economic damage on a global scale, in part the result of the longevity and environmental robustness of their dispersal stages, their eggs. Arguably the most successful and widely distributed nematode parasite of humans is Ascaris lumbricoides, which infects over 1 billion people. A morphologically indistinguishable species, Ascaris suum, occurs in pigs and has become the best understood nematode in biochemical terms. The eggs contaminate soil, and the embryos develop to infective, second-stage larvae (L2s)1 within the eggs. The L2 undergoes developmental arrest until ingestion by the host, and may survive for up to 7 years, but little is known of the biochemical basis for such long term survival. The problems faced by the L2 include maintaining both the egg's impermeability to water and dissolved ions (they can survive in dilute formalin and sulfuric acid) and its permeability to oxygen, as well as the potential accumulation of toxic products of lipid peroxidation. The ascarid L2 develops in the perivitelline fluid enclosed within the highly resistant, chitinous eggshell (1). The innermost lipid layer of the eggshell accounts for the extreme impermeability and resistance and is composed of three unusual, structurally related glycosides, the ascarosides (1-3). Perturbation of this ascaroside layer appears to be involved in the initiation of the hatching process upon infection of a new host (4-6). The organism, therefore, has particular need of a mechanism to transport and store hydrophobic compounds between the larva and the eggshell.

The present study was initiated to identify major proteins in the perivitelline fluid of A. suum infective larvae, specifically those potentially involved with the maintenance of the highly resistant lipid layer. Toward this end, we have identified a novel fatty acid-binding protein (FABP), designated As-p18, in the perivitelline fluid surrounding the infective L2. Based on sequence and structure analysis, and its fatty acid binding function, As-p18 is an unusual member of lipid-binding protein (LBP) family in having a hydrophobic leader sequence, being under strong developmental regulation, and in terms of its predicted structure.


EXPERIMENTAL PROCEDURES

Parasites

Adult A. suum females were obtained from Routh Packing (Sandusky, OH). Unembryonated eggs (day 0) were collected from uteri and incubated at 25 °C for 10 and 30 days to obtain first-stage larvae (L1s) and second-stage larvae (L2s), respectively, as described previously (7). Third-stage larvae (L3s) were recovered from rabbit lungs 7 days post-infection with 3 × 105 L2s as described previously (8, 9).

Preparation of Samples for Electrophoresis

L2s were artificially hatched, as modified from Urban et al. (7). Briefly, L2s were treated with 5.25% sodium hypochlorite for 10 min at room temperature. Eggshells were disrupted with glass beads by gentle stirring at 37 °C in Earle's balanced salt solution with protease inhibitor mixture A (20 µg/ml pepstatin A, 20 µg/ml chymostatin, 20 µg/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride, 1 mM benzamidine, 2 mM EDTA, 2 mM EGTA). The suspension was centrifuged at 200 × g for 10 min, and the resulting supernatant was centrifuged at 155,000 × g for 1 h at 4 °C. The hatching fluid was concentrated and exchanged by ultrafiltration (Centricon 10, Amicon) into 20 mM MOPS, pH 7.2, containing protease inhibitor mixture A.

Larvae were disrupted by treatment in a French pressure cell at 20,000 p.s.i. in 20 mM MOPS, pH 7.2, containing protease inhibitor mixture B (mixture A plus 20 µg/ml aprotinin, 20 µg/ml soybean trypsin inhibitor, 40 µg/ml antipain, and 20 µg/ml caproic acid). All adult tissues were homogenized in 20 mM MOPS, pH 7.2, with protease inhibitor mixture B. Larval and adult homogenates were brought to 1% with Triton X-100 on ice for 30 min and centrifuged at 10,000 × g for 30 min at 4 °C before concentration of the supernatant by ultrafiltration, as outlined above. Protein concentrations were estimated by the Bradford method (Bio-Rad). All samples were aliquoted, lyophilized, and stored at -80 °C until use.

Two-dimensional Gel Electrophoresis

Isoelectric focusing electrophoresis was performed on precast Immobiline dry strips (linear gradient, pH 3-10, 11 cm) with a Multiphor II electrophoresis system (Pharmacia Biotech Inc.) following the manufacturer's instructions with minor modifications according to Westermeier (10) and Ji et al. (11). Briefly, the Immobiline dry strips were rehydrated in 8 M urea, 0.2% dithiothreitol (DTT), 0.5% Triton X-100, and 0.5% Nonidet P-40 overnight. Lyophilized homogenates (300 µg) were dissolved in 100 µl sample buffer (9 M urea, 1% DTT, 2% Ampholine, pH 3.5-9.5, 2% Nonidet P-40, and 0.005% bromphenol blue), loaded on the acidic end of the strip and run for 21,125 volt-hours (V-h) in three continuous phases: phase I, 75 V-h (150 V, 30 min), phase II, 1500 V-h (300 V, 5 h); and phase III, 19,550 V-h (1150 V, 17 h). The strips were stored at -80 °C for less than 3 months before use. Before running the second dimension, each strip was equilibrated in 10 ml of 50 mM Tris-HCl, pH 6.8, 6 M urea, 30% glycerol, 2% SDS, 10 mg/ml DTT, and 0.0015% bromphenol blue for 20 min with gentle agitation. The second dimension was run on 12% SDS-polyacrylamide gels according to Laemmli (12). The gels were either stained with Coomassie Blue to visualize proteins or transferred to Problott membranes (Applied Biosystems) for NH2-terminal amino acid sequencing.

Amino Acid Sequencing

Proteins separated by two-dimensional gel electrophoresis were transferred to a Problott membrane (Applied Biosystems) in 10 mM CAPS buffer, pH 11, with 10% methanol according to the manufacturer's instructions. Proteins of interest were excised from the membrane and the NH2-terminal amino acid sequences were analyzed with a model 477A Protein Sequencer (Applied Biosystems).

cDNA Cloning and Sequencing

The full-length cDNA of As-p18 was cloned from cDNA prepared with a Marathon kit (Clontech). Briefly, cDNAs were synthesized from total RNA isolated from day 5 A. suum eggs, and the double-stranded cDNAs then were adapted with adapter primer 1 (AP-1) and primer 2 (AP-2). With these adapted double-stranded cDNAs as a template, a degenerate sense primer (primer A, 5'-GA(C/T) AA(A/G) TT(C/T) (C/T)T(N) GG(N) AC(N) TT(C/T) AA-3') designed from NH2-terminal amino acid sequence of As-p18 (DKFLGTFK) and the AP-1 primer were used for 3'-RACE. The 3'-RACE PCR products were analyzed on a 1% agarose gel and a weak band at about 600 base pairs was purified from the gel by GENO-BIND (Clontech). The purified DNA was used as template for nested PCR with primer A and AP-2 primer. The nested PCR products were analyzed on a 1% agarose gel. The DNA at about 600 base pairs was purified from the gel by GENO-BIND (Clontech), cloned into pNoTA/T7 vector (5'-3', Inc.), and both strands sequenced by the dideoxynucleotide chain termination method of Sanger et al. (13) using Sequenase 2.0 (U.S. Biochemical Corp.). According to the sequence of the nested PCR product, two complementary gene-specific primers (primer B, 5'-TCC TTG TGA TGC GTG TCT TTC-3'; primer C, 5'-GAA AGA CAC GCA TCA CAA GGA-3') were designed. Primer B and primer C were used with AP-1 for 5'-RACE and 3'-RACE, respectively, with the adapted day 5 cDNA. These 5'-RACE and 3'-RACE products were fused to prepare the full-length cDNA, which was both strands sequenced as described above.

Northern Blotting

Total RNAs from different developmental stages and adult tissues were isolated by acid guanidinium thiocyanate-phenol-chloroform extraction according to Chomczynski et al. (14). Total RNA (20 µg) was separated on a 1% agarose formaldehyde denatured gel and transferred to a Nytran Plus positively charged nylon membrane (Schleicher & Schuell), and the membrane was baked in a vacuum oven at 80 °C. The full-length As-p18 cDNA was used as a probe after labeling with [32P]dCTP and purification on a NICK column (Pharmacia). The membrane was hybridized and autoradiographed at -80 °C.

Construction of Expression Vector for As-p18

A cDNA encoding the full-length mature As-p18 protein was expressed in the pQE-30 vector (QIAGEN), which is designed to produce a recombinant protein bearing a 6xHis tag at the NH2 terminus. A BamHI site was added to the 5' end immediately before the nucleotide (nt 72) coding for the first amino acid of the mature protein, and a PstI site was added to the 3'-untranslated region at nt 603-608 by PCR with primer D (5'-G GTT AAG ACT CTA CCC GAC-3') and primer E (5'-GC AAT TAA CAG ATG ATC AG-3'), respectively. The PCR fragment at about 550 base pairs was cloned into pCR II vector (Invitrogen). The 532-base pair BamHI/PstI fragment digested from pCR II/As-p18 plasmid DNA was cloned into pQE-30 vector via BamHI/PstI sites. This pQE-30/As-p18 plasmid was transformed into M15 (pREP4) strain of Escherichia coli (QIAGEN) and both strands sequenced, as described above, to verify the insert sequence.

Expression and Purification of Recombinant Protein

E. coli with the pQE-30/As-p18 were cultured in LB medium (10 g of tryptone, 5 g of yeast extract, and 5 g of NaCl/liter) until the absorbance at 600 nm reached 0.6 units. Expression of recombinant As-p18 (rAs-p18) was induced by 1 mM isopropyl-thio-beta -D-galactopyranoside for 4 h at 37 °C. rAs-p18 was purified by affinity chromatography on Ni-NTA-agarose (QIAGEN) under nonreducing conditions. Briefly, bacteria were sonicated on ice in 50 mM NaH2PO4, 300 mM NaCl, pH 7.8 and the lysate was centrifuged at 12,000 × g for 20 min at 4 °C. Triton X-100 (0.5% final concentration) was added and the solution was gently stirred with Ni-NTA-agarose for 60 min on ice. The resin was then loaded into a column, washed with 50 mM NaH2PO4, 300 mM NaCl, 10% glycerol, pH 6.0, and eluted with a gradient of 0-300 mM imidazole. The purified rAs-p18 was concentrated in 10 mM Tris-HCl, pH 7.5, by ultrafiltration (Centricon 10, Amicon) and stored at -80 °C in small aliquots. This procedure provided approximately 16 mg of rAs-p18/liter of culture. Recombinant ABA-1 (rABA-1) allergen from A. lumbricoides was produced by similar methods, as will be described in detail elsewhere.2

Antibody Generation and Immunoblotting

Purified rAs-p18 was separated on 12% SDS-polyacrylamide gels and used to immunize rabbits as described previously (15). Antibodies against rAs-p18 were affinity-purified using protein bound to CNBr-activated Sepharose 4B (Sigma) according to Kent (16). For immunoblotting, samples were separated on 12% SDS-polyacrylamide gels and transferred to nitrocellulose membranes. Membranes were blocked with 1% bovine serum albumin (BSA), incubated with primary antibody and alkaline phosphatase-conjugated goat anti-rabbit IgG secondary antibody, and developed with nitro blue tetrazolium and 5'-bromo-4-chloro-3-indolyl phosphate.

Spectrofluorimetry and Fluorescence-based Ligand Binding

Fluorescence measurements were made at 20 °C with a Spex FluorMax spectrofluorimeter (Spex Industries), using 2 ml samples in a silica cuvette. Raman scattering by the solvent was corrected for where necessary using appropriate blank solutions. The fluorescent fatty acid analogs 11-((5-dimethylaminonaphthalene-1-sulfonyl) amino)undecanoic acid (DAUDA), and dansyl-DL-alpha -aminocaprylic acid (DACA) were obtained from Molecular Probes and Sigma, respectively. All-trans-retinol and oleic acid were also obtained from Sigma. The dansylated fatty acids were stored as stock solutions (~1 mg ml-1 in ethanol) in the dark at -20 °C. They were freshly diluted to 1 µM with phosphate-buffered saline (PBS; 171 mM NaCl, 3.35 mM KCl, 10 mM Na2PO4, 1.8 mM KH2PO4) pH 7.2, before use in the fluorescence experiments. Competitors of fluorescent fatty acid binding were prepared as stock solutions (~10 mM in ethanol) and diluted in PBS before use. Retinol binding to proteins was tested by adding retinol (6 µl of a freshly prepared 180 µM solution in ethanol) directly to a cuvette containing protein in PBS. Reference proteins BSA, beta -lactoglobulin (bovine), ribonuclease A, ovalbumin (chicken), and transferrin (bovine) were obtained from Sigma and prepared as 10 mg ml-1 stock solutions in PBS. For estimation of the dissociation constant, successive 5- or 10-µl samples of rAs-p18 (at a monomer concentration (assuming monomeric dispersion) of 26.9 µM) were added to 2 ml of 0.7 µM DAUDA, and the fluorescence measured at 476 nm (lambda exc = 345 nm). The concentration of the ethanol stock solution of DAUDA was checked by absorbance of a 1:10 dilution in methanol at 335 nm, using an extinction coefficient epsilon 335 of 4400 M-1 cm-1. The concentration of rAs-p18 was estimated by absorbance at 280 nm, using an extinction coefficient of epsilon 280 = 27310 M-1 cm-1, based on the amino acid composition of the recombinant protein (17). Fluorescence data were corrected for dilution, and fitted by standard nonlinear regression techniques (using Microcal ORIGIN software) to a single noncompetitive binding model to give estimates of the dissociation constant (Kd) and maximal fluorescence intensity (Fmax). Similar nonlinear regression methods were used to analyze results of competition experiments in which oleic acid was progressively added to DAUDA/rAs-p18 mixtures. A stock solution of oleic acid in ethanol was freshly diluted to 10.6 µM in PBS, and increasing concentrations of oleic acid were added to a mixture containing 0.71 µM DAUDA and 0.94 µM rAs-p18. For all of the fluorescence-based experiments, residual detergent was removed from rAs-p18 solutions by passage through an Extracti-Gel D column (Pierce).

Circular Dichroism

Circular dichroism (CD) spectra were recorded at 20 °C in a JASCO J-600 spectropolarimeter using quartz cells of path length 0.02 or 0.05 cm. The protein concentration was 0.3 mg ml-1, as estimated by absorbance at 280 nm, in PBS. Molar ellipticity values were calculated using a value of 118 Da for the mean residue weight calculated from the amino acid sequence of rAs-p18 protein. Analysis of the secondary structure of the protein was performed using the CONTIN procedure (18) over the range from 240 to 195 nm.

Structural Predictions

Protein sequence comparisons were carried out with the BLAST (19) program to search the protein sequence data base (blastp). MaxHom (20) through SwissProt and Wisconsin Sequence Analysis Package (GCG) were used for protein sequence alignment. Secondary structure predictions were made using the PHD (21-23) program at SwissProt and GOR (24). Molecular mass and theoretical pI values for As-p18 were calculated with the ProtParam program through the SwissProt and GCG packages.

The As-p18 structure was modeled on the structure of mouse adipocyte lipid-binding protein (ALBP, Protein Data Bank code 1ADL) determined at 1.6-Å resolution by Lalonde et al. (25). A sequence alignment based on that produced by the PHD program on the Predict-Protein server (23) was used to direct the mutation of residues in the mouse protein to those of As-p18 using the program O (26). Three insertions were added using the lego-loop option, selecting by inspection the loop with the smallest root-mean-square deviation of base residue positions that had no significant Van der Waals overlap of atoms. Following energy minimization of the entire molecule, these loops were subjected to 2000 iterations (1 ps) of two-step Verlet molecular dynamics at 300 K; 2000 iterations at 200 K and 2000 at 100 K. This was followed by restrained energy minimization to convergence of the entire molecule and finally unrestrained energy minimization to convergence. Molecular simulation calculations were performed using the X-PLOR program and the CHARMM force field (27).


RESULTS

The As-p18 Protein and Cloning of Its Encoding cDNA

Perivitelline fluid was recovered from infective A. suum eggs after mechanical disruption and analyzed by two-dimensional gel electrophoresis and NH2-terminal sequencing of selected proteins (Fig. 1). Seven abundant proteins with apparent molecular weights of about 50, 43a, 43b, 18, 16, 13, and 12.5 kDa were discernible by this procedure, in addition to a number of minor components. The NH2-terminal amino acid sequence of the protein, which migrated at about 18 kDa and a pI of 7.8, exhibited similarity to a group of small, water-soluble iLBPs including fatty acid- and retinoid-binding proteins identified from a variety of different organisms (Figs. 2 and 3). This protein was designated As-p18 and selected for further study.


Fig. 1. Two-dimensional gel electrophoresis of perivitelline fluid prepared from infective A. suum larvae. A. suum L2s were artificially hatched as described under "Experimental Procedures." Perivitelline fluid (300 µg of protein) was analyzed by two-dimensional gel electrophoresis and stained with Coomassie Blue, as described under "Experimental Procedures." The arrow indicates As-p18.
[View Larger Version of this Image (36K GIF file)]



Fig. 2. Nucleotide and predicted amino acid sequence of As-p18. cDNA encoding As-p18 was cloned and sequenced as described under "Experimental Procedures." The 17-amino acid NH2-terminal sequence determined by direct sequencing of the As-p18 spot obtained from a two-dimensional gel is underlined, as is a consensus polyadenylation signal in the 3'-untranslated region.
[View Larger Version of this Image (50K GIF file)]



Fig. 3. Predicted amino acid sequence of As-p18 aligned with iLBP sequences from other sources. Dots indicate identity with As-p18. The boxed area is the NH2-terminal sequence determined by direct sequencing of As-p18. The amino acids of As-p18 are numbered.
[View Larger Version of this Image (53K GIF file)]


The cDNA encoding a fragment of As-p18 was isolated by PCR using degenerate oligonucleotides designed from the amino-terminal amino acid sequence generated from material eluted from two-dimensional gels. Full-length sequence for the As-p18 cDNA was then obtained by 3'- and 5'-RACE from day 5 egg cDNAs prepared as described under "Experimental Procedures." The sequence contained 628 nucleotides with a portion of the 22-nucleotide spliced leader sequence (SL1) characteristic of many nematode mRNAs (5'-CCA AGT TTG AG-3', Fig. 2) (28). Downstream of the SL1 sequence, no 5'-untranslated region was apparent, as the initiation ATG codon immediately followed the spliced leader, and an open reading frame of 492 nucleotides ended with the termination codon TAA. The 3'-untranslated region of 125 nucleotides contained a sequence identical to the consensus polyadenylation signal, AATAAA, and a short poly(A) tail after the polyadenylation signal. The open reading frame predicts a protein with a molecular mass of 19,077 Da including a hydrophobic leader peptide of 20 amino acids which was not observed at the amino terminus of the mature, egg-derived protein (Fig. 3). This leader peptide exhibited features characteristic of secretory signals identified in other organisms (29). The predicted molecular mass of the mature As-p18 was 16,911 Da, and its theoretical pI was 7.1 by the ProtParam program and 7.8 by the GCG packages, respectively.

Comparison of the As-p18 sequence with protein sequences available in the data bases indicated that it had greatest similarity to iLBPs from variety of other sources ranging from flatworms to mammals and it was most similar to proteins predicted from the Caenorhabditis elegans genome project (see Fig. 3 for alignment), which are presumed to be LBPs based on their alignment with LBPs from non-nematode parasitic helminths and mammals. At the amino acid level, As-p18 exhibited 43% identity to C. elegans LBP-1 (GenBankTM accession no. U40420[GenBank], protein identification code 1065518), 42% to C. elegans LBP-2 (GenBankTM accession no. U40420[GenBank], protein code 1065519), 33% to mouse ALBP, 32% to rabbit myelin P2 protein, 30% to Fasciola hepatica FABP, 29% to mouse brain FABP, 28% to Schistosoma mansoni FABP and Echinococcus granulosus FABP, and 27% to bovine heart FABP (25, 30-35). The nematode sequences were the only ones arising from the data base searches which had hydrophobic leader peptides. The nematode sequences had many more residues in common than with the other iLBPs, although residues conserved across the entire array were apparent. The nematode proteins also had two insertions of three and four amino acids in similar positions, which are absent in the other iLBPs. The cleavage site for the leader peptide is between Ala-20 and Lys-21 of As-p18, as defined by the NH2-terminal amino acid analysis of protein isolated from A. suum eggs, and this is also the most probable cleavage site identified by the Signalp program, based on neural networks trained on eukaryotic sequences (36). The Signalp program also predicts cleavage sites in the C. elegans proteins precisely aligning with that for As-p18.

The Expression of As-p18 Is Developmentally Regulated

Early A. suum larval stages and adult tissues were examined for As-p18 by immunoblotting with affinity-purified antiserum against rAs-p18. Immunoblotting analysis revealed that As-p18 was absent in day 0 unembryonated eggs, began to be synthesized at about day 3 of development, was abundant at day 10 (when the L1 is formed), and remained abundant in eggs containing the infective L2. However, As-p18 could not be detected either in the parasitic L3 or adult A. suum muscle, ovaries, testis, or intestine (Fig. 4A).


Fig. 4. Developmental regulation of As-p18. A, immunoblot of A. suum larval stages and adult tissues with affinity-purified antiserum against rAs-p18. Homogenates (35 µg of protein) of A. suum unembryonated eggs (D0), day 3 (D3), L1, L2, L3, adult muscle (M), ovaries (O), testis (T), and intestine (I) were separated on a 12% SDS-polyacrylamide gel and transferred to a nitrocellulose membrane. The membrane was incubated with affinity-purified antiserum against rAs-p18 and developed as described under "Experimental Procedures." B, Northern blot of A. suum RNA isolated from different larval stages and adult tissues using a cDNA clone for As-p18 as probe. Total RNA (20 µg) from larval stages and adult tissues as in panel A was separated on a formaldehyde denatured 1% agarose gel and transferred to a nylon membrane. The membrane was hybridized with a full-length 32P-labeled As-p18 cDNA probe and exposed for 3 days at -80 °C.
[View Larger Version of this Image (35K GIF file)]


Northern blotting using the radiolabeled full-length cDNA as a probe identified a single mRNA species of about 0.7 kb in total RNA extracted from Day 3 eggs, L1, and L2 (Fig. 4B). Surprisingly, significant bands of this size were also observed in Northern blots of RNA extracted from unembryonated eggs, ovaries, and especially L3s, even though the As-p18 protein could not be demonstrated by immunoblotting of these stages. To confirm the identity of the mRNA observed in ovaries and L3s on Northern blots, As-p18-specific primers were designed and used for PCR of cDNA pools prepared from mRNA isolated from both ovaries and L3s. The sequences obtained from both sources were identical to that of full-length As-p18 (data not shown).

To localize As-p18 during early larval development, infective L2 were hatched artificially, and both hatched larvae and hatching fluid were analyzed by SDS-PAGE and immunoblotting with affinity-purified antiserum against rAs-p18. As expected, As-p18 was present primarily in the hatching fluid, but a weak signal was also observed from the hatched L2s rinsed free from hatching fluid (data not shown). Immunolocalization and in situ hybridization experiments are currently in progress to identify the cells responsible for As-p18 synthesis.

Structural Analysis

The sequence of As-p18 aligns with iLBPs whose structures are known from x-ray crystallographic studies (37). These iLBPs are beta -sheet-rich proteins, which have 10 antiparallel beta -sheets forming so-called beta -barrel or beta -clam structures, with one or two short helices closing one end of the barrel. The ligand is held within a cavity in the center of the barrel, where it is removed from solvent and thereby protected from oxidation. The PHD program predicts As-p18 to be beta -rich (19.0% helix, 35.0% extended/beta -structures, and 46.0% remainder) based on multiple alignments assembled from the As-p18 sequence and similar mammalian proteins by the MaxHom routine, and GOR predicts 14.2% helix, 59.1% extended/beta -structure. The predictions of predominance of beta -sheet structures are borne out by circular dichroism of rAs-p18. The far-UV circular dichroism spectrum of rAs-p18 (Fig. 5) showed a strong beta -signal, and analysis of the data obtained over the range 240 to 195 nm by the CONTIN procedure provided the following estimates of secondary structure: 62% beta -sheet and less than 5% alpha -helical content. This estimate is close to the known content of beta -structure from crystal structures of iLBPs (37-40).


Fig. 5. Circular dichroism spectrum of rAs-p18. The spectrum was recorded at 20 °C in PBS, path length 0.02 cm.
[View Larger Version of this Image (14K GIF file)]


Modeling of the As-p18 sequence to mouse ALBP (25), the iLBP most similar to As-p18, demonstrated that the protein can be successfully modeled as a beta -barrel with two short helices, although modifications have to be made to accommodate the amino acid insertions (Fig. 6A). These have been made in loop regions with the first insertion adding an extra turn of helix to the second alpha -helical region. The second insertion is close to a loop region. The third loop insertion is between beta -strands 7 and 8 and has the effect of increasing the enclosure of the lipid-binding site, although a separate, currently unsuspected, function could still be attributed to this region.


Fig. 6. Structural modeling of As-p18. A, model of the structure of As-p18. Ribbon representation of the predicted structure, based on the crystal structure of mouse ALBP. The positions of the three insertions which occur in As-p18, but not in mouse ALBP or other similar proteins, are shown. B, the predicted structure of the ligand binding site of As-p18 and the space available for ligand occupancy. The labeled residues projecting into the cavity are responsible for the formation of the predominately hydrophobic cavity and maintenance of the charge distribution on the cavity surface. Tyr-160, Asn-67, Asn-80, His-88, and the backbone of Glu-101 create a four-link hydrogen-bond chain forming one face of the ligand-binding cavity.
[View Larger Version of this Image (32K GIF file)]


The final model of As-p18 has 96.1% of residues in the two most-favored regions of the Ramachandran plot and an acceptable overall geometry, both determined with Procheck (41). There is a single major cavity in the protein interior as determined by the program Voidoo (42). The volume available to a probe of radius 1.4 Å in this cavity is 335 Å3, also determined using Voidoo. It is an artifact of the modeling process used that a cavity within a protein will contract during the energy minimization stage. The alternative is to model the protein with a ligand filling the cavity, thus partially predefining the results of the experiment. This was considered less acceptable than a small artificial contraction of the ligand-binding cavity. Nevertheless, the cavity remains of a suitable size to bind fatty acid ligands; oleic acid is approximately 300 Å3 while retinol occupies 330 Å3, as calculated from the volume which these ligands occupy within the known crystal structures of their binding proteins. The cavity is shown in Fig. 6B. In mouse ALBP, Arg-126 is available to bind a fatty acid carboxylate group, while in As-p18 the corresponding Arg (Arg-158) is charge-neutral in combination with Asp-36, invariably a serine in other similar proteins, and so less available for carboxylate binding. The remainder of the ligand-binding cavity is lined with either hydrophobic residues or with hydrogen-bonded hydrophilic side chains. The only exceptions to this are Arg-46, which has its side chain directed toward the cavity, and Lys-90. Both these anomalies can be explained from the differences between the consensus sequence and that of As-p18. Arg-46 probably replaces Arg-158 in binding the fatty acid carboxylate group, while Lys-90 forms a charge pair with Asp-100, making this region of the ligand binding pocket also charge-neutral.

Additional evidence for the accuracy of this model, especially the insertions, is found in the positioning of the nonpolar hydrophilic side chains in the ligand-binding cavity. The positioning of Tyr-160, Asn-67, Asn-80, His-88, and the backbone of Glu-101 creates a four link hydrogen-bond chain forming one "wall"' of the ligand-binding cavity.

Fatty Acid Binding Activity of Recombinant As-p18

As-p18 was expressed in E. coli without its putative leader peptide but with a His6 affinity tag at its amino terminus and six additional amino acids derived from the vector (see "Experimental Procedures"). rAs-p18 was soluble under nonreducing conditions and was purified to apparent homogeneity by chromatography on Ni-NTA-agarose. Under SDS-PAGE on 12% gels, its apparent molecular mass was 22 kDa, while the calculated molecular mass is 18,309 Da (data not shown).

The fatty acid binding capacity of rAs-p18 was examined using fluorescent lipid analogs, as described previously (43, 44). The emission spectrum of DAUDA is altered upon entry into fatty acid-binding proteins (45) and binding to rAs-p18 was accompanied by a substantial increase of fluorescence intensity and a shift in the fluorescence emission peak from 543 nm to 498 nm (Fig. 7). To place this blue shift in context, rat liver FABP, BSA, and the ABA-1 allergen of A. suum produce shifts in DAUDA emission to 500, 495, and 475 nm, respectively (43, 45). The degree of the shift in the dansyl fluorophore emission is considered to be a measure of the polarity of the binding site (46), and that brought about by rAs-p18 is similar to other iLBPs. Titration of rAs-p18 with DAUDA yielded an apparent dissociation constant (Kd) of (1.2 ± 0.5) × 10-7 M (Fig. 8). The binding of a natural, nonfluorescent ligand (oleic acid) was then determined from its competitive effects on the fluorescence of the rAs-p18·DAUDA complex. The progressive addition of oleic acid to the rAs-p18·DAUDA complex caused a stoichiometric reversal of the fluorescence effect, presumably by the displacement of DAUDA from As-p18. Analysis of the oleic acid titration curve yielded an apparent Kd (oleic) of approx  2 × 10-8 M (Fig. 8), which is within the range of Kd found for other iLBPs (47).


Fig. 7. Fatty acid binding activity of rAs-p18. Fluorescence emission spectra (uncorrected, lambda exc = 345 nm) of 1 µM DAUDA in PBS or with 2.2 × 10-7 M rAs-p18. Also shown is the reversal of changes in DAUDA emission by competition with 5.85 × 10-7 M oleic acid added to the rAs-p18·DAUDA complex. The difference spectrum is the subtraction of the spectrum of DAUDA alone from DAUDA + rAs-p18, and shows the fluorescent emission of DAUDA while in the binding site of the protein.
[View Larger Version of this Image (23K GIF file)]



Fig. 8. Titration curves for the binding of DAUDA and oleic acid to rAs-p18. A, increase in relative fluorescence intensity on progressive addition of recombinant As-p18 to DAUDA. The solid line is the theoretical binding curve for rAs-p18 to DAUDA with an apparent dissociation constant of about 1.2 × 10-7 M. B, stoichiometric decrease in relative fluorescence intensity due to the displacement of DAUDA from rAs-p18 by oleic acid. The solid line is the theoretical curve for simple competitive binding of oleic acid in the DAUDA binding site of As-p18 with an apparent KI(oleic) of approximately 2 × 10-8 M.
[View Larger Version of this Image (15K GIF file)]


We also investigated binding of rAs-p18 to a fluorescent fatty acid, DACA, in which the dansyl fluorophore is attached at the alpha  carbon, rather than the hydrocarbon terminal, as is DAUDA. The DACA probe was found not to alter its fluorescence characteristics when mixed with rAs-p18, although it bound well to BSA and rABA-1 in control experiments (data not shown). This lack of DACA binding may indicate that the mechanism of binding of fatty acids is different from BSA and ABA-1, or merely that the dansyl group interrupts the hydrogen bonding network which anchors the carboxylate group in iLBPs (48).

Several of iLBPs bind retinol in addition to fatty acids, so As-p18 was also tested for retinol binding by fluorescence. Since retinol is highly unstable in water, the fatty acid binding assay was modified so that retinol was added directly to the rAs-p18 solution in the fluorescence cuvette. This assay yielded no evidence of binding by rAs-p18, although control proteins BSA, bovine lactoglobulin and rABA-1 all showed strong binding, as revealed by a dramatic increase in the intensity of fluorescence of retinol (data not shown).

Many proteins that bind fatty acids have a tryptophan residue in or near the binding pocket of the protein, the fluorescence emission of which is altered upon ligand binding, presumably through direct involvement in ligand binding, alteration in the environment of the tryptophan, or local changes in protein conformation. This has been observed for beta -lactoglobulin and for serum albumin (43, 49), and, in the case of the former, this effect has been used to measure the affinity of ligand binding (49). As-p18 has three tryptophan residues, and excitation of these at 287 nm produced an emission spectrum that peaked at 339 nm (data not shown). Although this is a compound spectrum from the emission from three tryptophan residues, the spectrum was simple, and there was a clear blue shift away from that of solvent-exposed tryptophan in denatured protein (355 nm, data not shown). Presumably this means that the tryptophans are removed from solvent water even in the apo-protein. For comparison, the peak emissions of the single tryptophans in beta -lactoglobulin, BSA, and ABA-1 are 335, 344, and 308 nm, respectively (data not shown and Ref. 43). There was no indication of a change in the tryptophan fluorescence of As-p18 upon addition of oleic acid ligand (data not shown). This suggests that the tryptophans in As-p18 are not close to the ligand, and none are associated with ligand binding.


DISCUSSION

We have demonstrated that the perivitelline fluid surrounding the developing larva of the parasitic nematode, A. suum, has a relatively simple polypeptide composition and have identified from it a novel, abundant fatty acid-binding protein, As-p18. The predicted amino acid sequence of As-p18 exhibits significant similarity to iLBPs isolated from a variety of different organisms, ranging from flatworms to mammals.

All LBPs appear to have similar conformations with 8 or 10 anti-parallel beta -strands and two short alpha -helices, even though some members of the group exhibit as little as 20% sequence identity (37-38, 48, 50). However, conserved positions have been identified. As-p18 exhibits a number of significant differences in these conserved regions and, with the exception of presumptive LBP-encoding sequences recently identified through the C. elegans genome project, is the only member of this group with a putative secretory signal. Of the 39 conserved polar and nonpolar positions in most iLBPs, 8 are not conserved in As-p18. For example, two invariant residues that correspond to Ser-55 and Phe-57 of the human ALBP are at a proposed portal region for ligand entry (37) and are not conserved in As-p18 (Glu-79 and Leu-81).

Sequence differences aside, however, As-p18 is clearly a functional fatty acid-binding protein. It has a high affinity for oleic acid, and there is strong evidence that it is structurally very similar to iLBPs, based on the preponderance of beta -sheet as indicated by the CD analysis and computer-based predictions of its secondary structure. However, while the modeling study does show that the sequence conforms well to a 10-stranded iLBP, there are indications of modifications to the binding site which could relate to ligand specificity. In addition, the unusual extra loops exposed on the surface of the protein might be involved in unsuspected protein-protein interactions.

Another unusual feature of As-p18 is the tight developmental control of its expression, which is not common among LBPs, although a few cases have been reported (51, 52). As-p18 is not present in unembryonated eggs, but begins to be synthesized at about day 3 and is abundant in the perivitelline fluid by the time the L1 is formed on day 10. The reasons for the apparent lack of As-p18 protein in these stages is unclear, but the data suggest that the maternal As-p18 mRNA in the unembryonated egg (53) may not be translated. For the L3, however, an alternative explanation may be that As-p18 is synthesized and immediately secreted, so it does not accumulate within the larva. As-p18 appears to be present in the perivitelline fluid prior to development of any of the secretory structures possessed by later stages of A. suum, and no As-p18 immunoreactivity has been detected in the duct leading to the secretory pore in infective L2.3 As-p18 must therefore arise in the perivitelline fluid by an unexpected route, and studies are under way to characterize the cells responsible for As-p18 synthesis and secretion into the perivitelline fluid before the development of a functional secretory system. In view of the similarity between As-p18 and the putative LBPs from C. elegans, it would seem valuable to investigate the developmental control, function and site of their synthesis in this organism. It is conceivable that one or both homologues are important to the survival of the embryo within the eggshell.

Although the function of As-p18 is unclear, a number of interesting possibilities are apparent. The early development of A. suum from unembryonated egg to infective L2 takes place entirely within a highly resistant eggshell, and the quiescent L2 can remain viable for several years while it awaits ingestion by an appropriate host (54). Carbohydrate is utilized during the first 5 days of development and then resynthesized from stored triglycerides by the glyoxylate cycle (55). Stored triglycerides are the only energy source for quiescent L2s, and the appearance of As-p18 in the perivitelline fluid parallels the increasing utilization of triglycerides as development proceeds (55, 56). As-p18 may therefore play a role by sequestering potentially toxic fatty acids and their peroxidation products accumulating around a larva enclosed within an impermeable eggshell. The resistance of the eggshell is thought to be due to a highly impermeable lipid layer comprised of unusual glycosides (ascarosides) secreted by the fertilized egg prior to the expression of As-p18 (3). We are currently testing the binding capacity of As-p18 for ascarosides and potential products of lipid peroxidation. As-p18 also may play a role in the altered permeability of the lipid layer that accompanies the onset of hatching. This altered permeability permits the diffusion of trehalose out of the perivitelline fluid, and this change in osmotic pressure is presumed to activate the quiescent larva whose subsequent movement may further mechanically disrupt the lipid layer (1, 5).

FABPs have been isolated from a number of flatworms, including S. mansoni, E. granulosus, and F. hepatica and have received attention as being potentially important in helminth parasitism. Indeed, the flatworm FABPs appear to be important antigens released during the course of infection with these helminths and have been identified as promising vaccine candidates (31, 33-34, 57). In addition, an ethanolamine-binding protein recently has been identified as a major antigen released during the larval migration of the related dog ascarid, Toxocara canis (58). Finally, the ABA-1 allergen produced by A. suum also displays strong fatty acid binding activity, even though it is quite different in structure from the LBPs (43, 59).

As-p18 is, therefore, a member of the beta -barrel lipid-binding proteins, which is unusual in the possession of a leader peptide in its precursor, and its lack of retinol binding. It is also the first member of this family from nematodes to be characterized as an FABP, and makes it probable that the proteins identified by similarity from C. elegans indeed represent functional FABPs. It clearly possesses some unique features, which may reflect adaptation to a specific function within the egg.


FOOTNOTES

*   This work was supported by National Institutes of Health Grant AI 18427 (to R. K.), and by Grant 044156 from the Wellcome Trust (to M. W. K. and A. Cooper (University of Glasgow)).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) U51906[GenBank].

The predicted structure model for As-p18 (code 1AS1) has been submitted to Protein Data Bank, Brookhaven National Laboratory, Upton, NY.


par    To whom correspondence should be addressed: Dept. of Biology, The University of Toledo, 2801 W. Bancroft St., Toledo, OH 43606-3390. Tel.: 419-530-2065; Fax: 419-530-7737; E-mail: rkomuni{at}uoft02.utoledo.edu.
1   The abbreviations used are: L2, second-stage (infective) larva; ALBP, adipocyte lipid-binding protein; AP-1, adapter primer 1; AP-2, adapter primer 2; BSA, bovine serum albumin; CAPS, 3-(cyclohexylamino)-1-propanesulfonic acid; DACA, dansyl-DL-alpha -aminocaprylic acid; dansyl, dimethylaminonaphthalene-1-sulfonyl; DAUDA, 11-(((5-(dimethylamino)-1-naphthalenyl)sulfonyl)amino)undecanoic acid; DTT, dithiothreitol; FABP, fatty acid-binding protein; iLBP, intracellular lipid-binding protein; L1, first-stage larva; L3, third-stage larva; LBP, lipid-binding protein; MOPS, 3-(N-morpholino)propanesulfonic acid; NTA, nitrilotriacetic acid; PBS, phosphate buffered saline; PCR, polymerase chain reaction; rABA-1, recombinant ABA-1; rAs-p18, recombinant As-p18; RACE, rapid amplification of cDNA ends; SL1, nematode spliced leader RNA; V-h, volt-hour(s).
3   B. Mei, P. R. Komuniecki, and R. Komuniecki, unpublished observation.
2   Y. Xia, N. Heaney, A. Cooper, and M. W. Kennedy, manuscript in preparation.

ACKNOWLEDGEMENTS

We are indebted to Prof. N. C. Price and Dr. S. Kelly at Stirling University, Stirling, United Kingdom for assistance with the circular dichroism, Dr. Alan Cooper at the University of Glasgow for help with the analysis of ligand binding data, Drs. Y.-J. Huang and E. Duran at The University of Toledo for helpful discussions, and Dr. Y. Xia and Fiona McMonagle at the University of Glasgow for supplying the recombinant ABA-1 protein. The circular dichroism facility at Stirling University is supported by the Biotechnology and Biological Sciences Research Council (United Kingdom). We also thank personnel in Routh Packing (Sandusky, OH) for allowing us to collect adult A. suum.


REFERENCES

  1. Fairbairn, D. (1957) Exp. Parasitol. 6, 491-554 [Medline] [Order article via Infotrieve]
  2. Tarr, G. E., and Fairbairn, D. (1973) Lipids 8, 7-16 [Medline] [Order article via Infotrieve]
  3. Wharton, D. (1980) Parasitology 81, 447-463 [Medline] [Order article via Infotrieve]
  4. Fairbairn, D. (1961) Can. J. Zool. 39, 153-162
  5. Barrett, J. (1976) Parasitology 73, 109-121 [Medline] [Order article via Infotrieve]
  6. Clarke, A. J., and Perry, R. N. (1980) Parasitology 80, 447-456 [Medline] [Order article via Infotrieve]
  7. Urban, J. F. J., Douvres, F. W., and Tromba, F. G. (1981) Proc. Helminthol. Soc. Wash. 48, 241-243
  8. Douvres, F. W., Tromba, F. A., and Malakatis, G. M. (1969) J. Parasitol. 55, 689-712 [Medline] [Order article via Infotrieve]
  9. Vanover-Dettling, L., and Komuniecki, P. R. (1989) Mol. Biochem. Parasitol. 36, 29-40 [Medline] [Order article via Infotrieve]
  10. Westermeier, R. (1993) Electrophoresis in Practice, pp. 197-228, VCH, Weinheim, Germany
  11. Ji, H., Whitehead, R. H., Reid, G. E., Moritz, R. L., Ward, L. D., and Simpson, R. J. (1994) Electrophoresis 15, 391-405 [Medline] [Order article via Infotrieve]
  12. Laemmli, U. K. (1970) Nature 227, 680-685 [Medline] [Order article via Infotrieve]
  13. Sanger, F., Nicklen, S., and Coulson, A. R. (1977) Proc. Natl. Acad. Sci. U. S. A. 74, 5463-5467 [Abstract]
  14. Chomczynski, P., and Sacchi, N. (1987) Anal. Biochem. 162, 156-159 [CrossRef][Medline] [Order article via Infotrieve]
  15. Diaz, F., and Komuniecki, R. (1995) Mol. Biochem. Parasitol. 75, 87-97 [CrossRef][Medline] [Order article via Infotrieve]
  16. Kent, U. M. (1994) in Immunocytochemical Methods and Protocols (Javois, L. C., ed), pp. 29-35, Humana, Totowa, NJ
  17. Gill, S. C., and von Hippel, P. H. (1989) Anal. Biochem. 182, 319-326 [Medline] [Order article via Infotrieve]
  18. Provencher, S. W., and Glöckner, J. (1981) Biochemistry 20, 33-37 [Medline] [Order article via Infotrieve]
  19. Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. (1990) J. Mol. Biol. 215, 403-410 [CrossRef][Medline] [Order article via Infotrieve]
  20. Sander, C., and Schneider, R. (1991) Proteins 9, 56-68 [Medline] [Order article via Infotrieve]
  21. Rost, B., and Sander, C. (1993) J. Mol. Biol. 232, 584-599 [CrossRef][Medline] [Order article via Infotrieve]
  22. Rost, B., and Sander, C. (1994) Proteins 19, 55-72 [Medline] [Order article via Infotrieve]
  23. Rost, B. (1996) Methods Enzymol. 266, 525-539 [CrossRef][Medline] [Order article via Infotrieve]
  24. Garnier, J., Osguthorpe, D. J., and Robson, B. (1978) J. Mol. Biol. 120, 97-120 [Medline] [Order article via Infotrieve]
  25. LaLonde, J. M., Levenson, M. A., Roe, J. J., Bernlohr, D. A., and Banaszak, L. J. (1994) J. Biol. Chem. 269, 25339-25347 [Abstract/Free Full Text]
  26. Jones, T. A., Zou, J. Y., Cowan, S. W., and Kjeldaard, M. (1991) Acta Crystallogr. A47, 110-119 [CrossRef]
  27. Brunger, A. T. (1987) X-PLOR Manual, Version 3.1: A System for X-ray Crystallography and NMR, Yale University Press, New Haven
  28. Nilsen, T. W. (1993) Annu. Rev. Microbiol. 47, 413-440 [CrossRef][Medline] [Order article via Infotrieve]
  29. von Heijne, G. (1986) Nucleic Acids Res. 14, 4683-4690 [Abstract]
  30. Narayanan, V., Barbosa, E., Reed, R., and Tennekoon, G. (1988) J. Biol. Chem. 263, 8332-8337 [Abstract/Free Full Text]
  31. Rodríguez-Pérez, J., Rodríguez-Medina, J. R., García-Blanco, M. A., and Hillyer, G. (1992) Exp. Parasitol. 74, 400-407 [Medline] [Order article via Infotrieve]
  32. Feng, L., Hatten, M. E., and Heintz, N. (1994) Neuron 12, 895-908 [Medline] [Order article via Infotrieve]
  33. Moser, D., Tendler, M., Griffiths, G., and Klinkert, M.-Q. (1991) J. Biol. Chem. 266, 8447-8454 [Abstract/Free Full Text]
  34. Esteves, A., Dallagiovanna, B., and Ehrlich, R. (1993) Mol. Biochem. Parasitol. 58, 215-222 [Medline] [Order article via Infotrieve]
  35. Billich, S., Wissel, T., Kratzin, H., Hahn, U., Hagenhoff, B., and Lezius, A. G. (1988) Eur. J. Biochem. 175, 549-556 [Abstract]
  36. Nielsen, H., Engelbrecht, J., Brunak, S., and von Heijne, G. (1997) Protein Eng.g 10, 1-6 [Abstract]
  37. Banaszak, L., Winter, N., Xu, Z., Bernlohr, D. A., Cowan, S., and Jones, T. A. (1994) Adv. Protein Chem. 45, 89-151 [Medline] [Order article via Infotrieve]
  38. Jones, T. A., Bergfors, T., Sedzik, J., and Unge, T. (1988) EMBO J. 7, 1597-1604 [Abstract]
  39. Sacchettini, J. C., Gordon, J. I., and Banaszak, L. J. (1989) J. Mol. Biol. 208, 327-339 [Medline] [Order article via Infotrieve]
  40. Cowan, S. W., Newcomer, M. E., and Jones, T. A. (1993) J. Mol. Biol. 230, 1225-1246 [CrossRef][Medline] [Order article via Infotrieve]
  41. Laskowski, R. A., MacArthur, M. W., Moss, D. S., and Thornton, J. M. (1993) J. Appl. Crystallogr. 26, 283-291 [CrossRef]
  42. Kleywegt, G. J., and Jones, T. A. (1994) Acta Crystallogr. D50, 178-185
  43. Kennedy, M. W., Brass, A., McCruden, A. B., Price, N. C., Kelly, S. M., and Cooper, A. (1995) Biochemistry 34, 6700-6710 [Medline] [Order article via Infotrieve]
  44. Kennedy, M. W., Britton, C., Price, N. C., Kelly, S. M., and Cooper, A. (1995) J. Biol. Chem. 270, 19277-19281 [Abstract/Free Full Text]
  45. Wilkinson, T. C., and Wilton, D. C. (1986) Biochem. J. 238, 419-424 [Medline] [Order article via Infotrieve]
  46. Macgregor, R. B., and Weber, G. (1986) Nature 319, 70-73 [Medline] [Order article via Infotrieve]
  47. Thumser, A. E. A., Evans, C., Worrall, A. F., and Wilton, D. C. (1994) Biochem. J. 297, 103-107 [Medline] [Order article via Infotrieve]
  48. Sacchettini, J. C., and Gordon, J. I. (1993) J. Biol. Chem. 268, 18399-18402 [Free Full Text]
  49. Frapin, D., Dufour, E., and Haertle, T. (1993) J. Protein Chem. 12, 443-449 [Medline] [Order article via Infotrieve]
  50. Müller-Fahrrnow, A., Egner, U., Jones, T. A., Rudel, H., Spener, F., and Saenger, W. (1991) Eur. J. Biochem. 199, 271-276 [Abstract]
  51. Heuckeroth, R. O., Birkenmeier, E. H., Levin, M. S., and Gordon, J. I. (1987) J. Biol. Chem. 262, 9709-9717 [Abstract/Free Full Text]
  52. Haunerland, N. H., Chen, X., Andolfatto, P., Chisholm, J. M., and Wang, Z. (1993) Mol. Cell. Biochem. 123, 153-158 [Medline] [Order article via Infotrieve]
  53. Cleavinger, P. J., McDowell, J. W., and Bennett, K. J. (1989) Dev. Biol. 133, 600-604 [Medline] [Order article via Infotrieve]
  54. Roberts, L. S., and Janovy, J. J. (1996) Foundations of Parasitology, pp. 419-432, William C. Brown Publishers, Dubuque, IA
  55. Barrett, J., Ward, C. W., and Fairbairn, D. (1970) Comp. Biochem. Physiol. 35, 577-586
  56. Barrett, J. (1981) Biochemistry of Parasitic Helminths, pp. 107-108, University Park, Baltimore, MD
  57. Tendler, M., Brito, C. A., Vilar, M. M., Serra-Freire, N., Diogo, C. M., Almeida, M. S., Delbem, A. C. B., da Silva, J. F., Savino, W., Garratt, R. C., Katz, N., and Simpson, A. J. G. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 269-273 [Abstract/Free Full Text]
  58. Gems, D., Ferguson, C. J., Robertson, B. D., Nieves, R., Page, A. P., Blaxter, M. L., and Maizels, R. M. (1995) J. Biol. Chem. 270, 18517-18522 [Abstract/Free Full Text]
  59. Tomlinson, L. A., Christie, J. F., Fraser, E. M., McLaughlin, D., McIntosh, A. E., and Kennedy, M. W. (1989) J. Immunol. 143, 2349-2356 [Abstract/Free Full Text]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.